Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Medical Device User Fee and Modernization Act reauthorization | Statement: [Food and Drug Administration Amendments Act of 2007, establishesProgram, Medical Device User Fee and Modernization Act reauthorization]

Target entity: Medical Device User Fee and Modernization Act reauthorization
Context triple: [Food and Drug Administration Amendments Act of 2007, establishesProgram, Medical Device User Fee and Modernization Act reauthorization]

• A. Medical Device Amendments of 1976
  The Medical Device Amendments of 1976 are U.S. legislation that established a comprehensive regulatory framework for the safety and effectiveness of medical devices, including classification, premarket approval, and performance standards.
• B. Food and Drug Administration Safety and Innovation Act of 2012
  The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
• C. Prescription Drug User Fee Act of 1992
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• D. Food and Drug Administration Amendments Act of 2007
  The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
• E. 21st Century Cures Act
  The 21st Century Cures Act is a U.S. federal law enacted in 2016 that accelerates medical product development and innovation, expands funding for biomedical research and mental health services, and modernizes the regulation of drugs and medical devices.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Medical Device User Fee and Modernization Act reauthorization
Triple: [Food and Drug Administration Amendments Act of 2007, establishesProgram, Medical Device User Fee and Modernization Act reauthorization]

The Medical Device User Fee and Modernization Act reauthorization is a U.S. law that renews and updates the FDA’s authority to collect user fees from medical device manufacturers in exchange for more timely and predictable device review and regulatory oversight.

Target entity: Medical Device User Fee and Modernization Act reauthorization
Target entity description: The Medical Device User Fee and Modernization Act reauthorization is a U.S. law that renews and updates the FDA’s authority to collect user fees from medical device manufacturers in exchange for more timely and predictable device review and regulatory oversight.

• A. Medical Device Amendments of 1976
  The Medical Device Amendments of 1976 are U.S. legislation that established a comprehensive regulatory framework for the safety and effectiveness of medical devices, including classification, premarket approval, and performance standards.
• B. Food and Drug Administration Safety and Innovation Act of 2012 chosen
  The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
• C. Prescription Drug User Fee Act of 1992
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• D. Food and Drug Administration Amendments Act of 2007
  The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
• E. 21st Century Cures Act
  The 21st Century Cures Act is a U.S. federal law enacted in 2016 that accelerates medical product development and innovation, expands funding for biomedical research and mental health services, and modernizes the regulation of drugs and medical devices.
• F. None of above.